LabGenomics Rises 7.76% Amid Uptrend in COVID-19 (Diagnostic Kit) Theme

On the 27th, the COVID-19 (diagnostic kit) theme rose by 3.14% compared to the previous day, showing strength, while LabGenomics, a related stock drawing attention, surged by 7.76% compared to the previous day. LabGenomics is known as a manufacturer of in vitro diagnostics and gene analysis services and products.

[Graph] Major stock price changes in the COVID-19 (diagnostic kit) theme

According to the analysis by Thinkpool RoboAlgorithm RASSI, LabGenomics ranked 2nd out of 33 stocks in the quant financial ranking by exceeding the theme’s average scores in growth, stability, and profitability. This can be interpreted as LabGenomics having a relatively high investment attractiveness compared to other stocks within the theme from a financial perspective.

[Table] Top stocks by financial scores within the theme

※ The quant financial scores are the results of RoboAlgorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.